Alpha Tau Medical Ltd (DRTS) Stock Forecast & Price Target
Alpha Tau Medical Ltd · NASDAQ
$11.60-0.61 (-5.00%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Alpha Tau Medical Ltd, 4 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets range widely, $8.00 to $17.00 (about 2.1x), a sign of real disagreement on valuation. The average target of $12.60 sits 9% above the current $11.60. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 2 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.14 next quarter toward $-0.51 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Moderate Buy
Strong Buy00%
Buy480%
Hold120%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Alpha Tau Medical Ltd.
As of Jul, 4 of 5 firms rate DRTS a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
DRTS EPS & revenue forecast
EPS · NEXT QUARTER
$-0.14
Range $-0.14 – $-0.13 · 4 analysts · -1% YoY
Next period, 4 analysts expect Alpha Tau Medical Ltd to earn $-0.14 a share (range $-0.14 – $-0.13), versus $-0.14 a year earlier. Full-year consensus is $-0.66, growing to $-0.51 the year after.
REVENUE · NEXT QUARTER
$491.0K
Range $0 – $1.0M · 4 analysts
Revenue is expected to reach $491.0K (range $0 – $1.0M). Full-year consensus is $1.6M, rising to $12.4M next year.
Top analysts covering Alpha Tau Medical Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DRTS.
#1
Yigal Nochomovitz
Citigroup · Rank #131
Buy
$9.00-22.4% to target
Overall win rate
43%
+ Follow
#2
Yi Chen
HC Wainwright & Co. · Rank #238
Buy
$15.00+29.3% to target
Overall win rate
34%
+ Follow
#3
Jason Bednar
Piper Sandler · Rank #303
Hold
$8.00-31.0% to target
Overall win rate
33%
+ Follow
#4
LS
Lukas Shumway
Barclays
Buy
$17.00+46.6% to target
Coverage
—
+ Follow
#5
JC
Jeff Cohen
Ladenburg Thalmann
Buy
$14.00+20.7% to target
Coverage
—
+ Follow
DRTS stock forecast FAQ
What is DRTS's average 12-month price target?+
The 5 analysts with a live target average $12.60 for Alpha Tau Medical Ltd over the next 12 months, ranging from a $17.00 high to a $8.00 low.
Is DRTS stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 5 analyst ratings, 4 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for DRTS?+
The Street-high target is $17.00 (Barclays), and the Street-low is $8.00 (Piper Sandler). The average of all 5 active targets is $12.60.
How many Wall Street analysts cover DRTS?+
5 analysts have an active rating on Alpha Tau Medical Ltd, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering DRTS?+
Among analysts who currently cover DRTS, Yigal Nochomovitz of Citigroup has the strongest overall Quantellect track record (Rank #131). Their current call is Buy with a $9.00 target.
What is Alpha Tau Medical Ltd's projected EPS for next quarter?+
The consensus estimate is $-0.14 per share (range $-0.14 – $-0.13) across 4 analysts. Full-year EPS is projected at $-0.66, rising to $-0.51 the following year.
How much revenue is Alpha Tau Medical Ltd expected to report next quarter?+
Consensus revenue is $491.0K (range $0 – $1.0M). Full-year revenue is projected at $1.6M, growing to $12.4M next year.
Have analysts been upgrading or downgrading DRTS lately?+
As of Jul, 4 of 5 firms rate DRTS a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DRTS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
